Dial 040-44885000 Or Press Here to Book an Appointment

Dr. Pratap Mouli Venigalla

Chief Consultant Medical Gastroenterology, Hepatology, Interventional Endoscopy & GI Physiology

OP Timings:

MondayTuesdayWednesdayThursdayFridaySaturdaySunday
09:00am - 05:00pm09:00am - 05:00pm
09:00am - 05:00pm
09:00am - 05:00pm
09:00am - 05:00pm
09:00am - 05:00pm
Not Available

Qualification / Education:

  • MBBS – Guntur Medical College, Jan 1999 – Nov 2004
  • MD (Medicine) – AIIMS, New Delhi, Jan 2005 – Dec 2007
  • DM (Gastroenterology) – AIIMS, New Delhi, Jul 2008 – Jun 2011
  • Senior Research Associate, Department of Gastroenterology, AIIMS, New Delhi, Jul 2011 – Dec 2013
  • Visiting Research Fellow, IBD Unit, Massachusetts General Hospital, Harvard Medical School, May – Jul 2013
  • Visiting Observer, Endoscopy Unit, Herlev Hospital, Denmark, Feb 2014
  • Visiting Observer, Endoscopy Unit, Jichi Medical University, Japan, Feb 2025

Academic Affiliation & Research Interests:

Ongoing academic collaboration in Inflammatory Bowel Disease (IBD) with Prof. Vineet Ahuja, AIIMS, New Delhi, contributing to research activities and publications

Expertise:

  • ERCP
  • EUS
  • IBD
  • GI Mobility
  • Hepatology

Awards:

  • Best student award, 1st MBBS (year 2000) (Vasireddy Seethapathy and Gowri Devi Endowment Award)
  • Gold Medal in ENT, 3rd MBBS (year 2002)
  • RK Tandon best outgoing DM Student Award (year 2011)
  • “Nature Reviews Gastroenterology & Hepatology Travel Grant : Gastro 2013 APDW/WCOG, Shangai”
  • Yong Investigator Award : APDW Kolkata, 2019

Accomplishments in Gastroenterology Services Regionally:

  • First to start & establish therapeutic EUS in the divided state of Andhra Pradesh.
  • First to start & establish both water perfusion and solid state high resolution esophageal and anorectal manometry in the divided state of Andhra Pradesh.
  • First to start & establish the GI motility unit in the divided state of Andhra Pradesh.
  • First to start & establish cPLEX for liver failure cases in the Liver Unit in the state of Andhra Pradesh.
Publications:

As First Author

1.Pratap Mouli V, Gupta A, Ahuja V. Diagnostic delay due to anti-tubercular therapy in Crohn’s disease: a red herring? J Crohns Colitis 2020 Jul 22;jjaa 155.doi:10.1093/ecco-jcc/jjaa 155.Online ahead of print.

2.Pratap Mouli V, Kedia S, Ahuja V. Letter: mucosal response in discriminating intestinal tuberculosis from Crohn’ diseae -when to look for it? Author’s reply. Alimentary Pharmacology and Therapeutics, 2018; 47: 860-861

3.Pratap Mouli V, Muntor K, Ananthakrishnan A, Kedia S, et al. Endoscopic and clinical response to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn’s disease.. Alimentary Pharmacology and Therapeutics, 2017; 45: 27-36.

4.Pratap Mouli V, Benjamin J, Bhushan Singh M, Mani K, Garg SK, Saraya A, Joshi YK. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy - a non-inferiority randomized controlled trail. Hepatology Research, 2015;45:880-9.

5.Pratap Mouli V, Ananthakrishnan A. Vitamin D and inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 2014; 39: 125-136.

6.Pratap Mouli V, Ahuja V. Colon rescue therapy in acute severe colitis. National Medical Journal of India, 2013; 26: 159-161.

7.Pratap Mouli V, Sreenivas V, Garg PK. Efficacy of conservative treatment, without necrosectomy, for infected pancreatic necrosis: a systematic review and meta-analysis, Gastroenterology, 2013;144: 333-340.

8.Pratap Mouli V, Gamnagatti S, Ahuja V. An unusual case of cyanosis in a young boy. Gastroenterology, 2013; 145: e5-6.

9.Pratap Mouli V, Ahuja V. Questionnaire based gastroesophageal reflux disease (GERD) assessment scales, Indian Journal of Gastroenterology, 2011; 30: 180-17.

10.Pratap Mouli V, Ahuja V. Proton pump inhibitors: concerns over prolonged use. Tropical Gastroenterology, 2011; 32: 175-84.

As co-author:

11.Vijay MK, Das P, Prabhu SB, Pratap Mouli V, Acharya SK, Mathur SR. Pleomorphic giant cell-rich hepatocellular carcinoma presented as a right atrials mass. Indian Journal of Pathology and Microbiology, 2011; 54:632-4.

12.Sharma PK, Suri TM, Pratap Mouli V, Garg SK, Mohammad G, Das P, Sood S, Saraya A, Ahuja V. Atrophic gastritis with high prevalence of Helicobacter pyloir is a predominant feature in patients with dyspepsia in a high altitude area. Tropical Gastroenterology, 2014; 35: 246-51.

13.Singla V, Pratap Mouli V, Garg SK, Rai T, Choudhury BN, Verma P, Deb R, Tiwari V, Rohatgi S, Dhingra R, Kedia S, Makharia G, Sharma PK, Ahuja V. Induction with NCB-02 (curcumin) enema in patients with mild-to-moderate distal ulcerative colitis - a randomized, double-blind, placebo-controlled, pilot study. Journal of Crohn’s and Colitis, 2014;8:208-214.

14.Khan AA, Pal S, Garg P, Pratap Mouli V, et al. Predicting postoperative pancreatic fistula (POPF) after pancreatic resections using preoperative endoscopic ultrasound (EUS) elastography (EUSE) : a prospective study. Pancreatology, 2014; 14 (Suppl): S8-S9.

15.Srivastava S, Kedia S, Kumar S, Pratap Mouli V, Dhingra R, Sachdev V, Tiwari V, Kurrey L, Pradhan R, Ahuja V. Serum human trefoil factor 3 is a biomaker for mucosal healtingin uncerative colitis patients with minimal disease activity. Journal of Crohn’s and Colitis, 2015;9L575-9.

16.Kedia S, Sharma R, Nagi B, Pratap Mouli V, Ananthakrishnan A, Dhingra R, Kurrey L, Srivastava S, Ahuja V. Computed tomography-based predictive model for differentiation of Crohn’s disease from Intestinal Tuberculosis. Indian Journal of Gastroenterology, 2015; 34: 135-143.

17.Singh B, Kedia S, Konijeti GG, Pratap Mouli V, Dhingra R, Kurrey L, Srivastava S, PradhanR, MakhariaG, Ahuja V. Extra-intestinal manifestations in patients of inflammatory bowel disease and intestinal tuberculosis: frequency and relation with disease phenotype. Indian Journal of Gastroenterology, 2015; 34: 43-50.

18.Rawat R, Gupta V, Pratap Mouli V, Shalimar, Saraya A. To compare endoscopic variceal ligation + carvedilol versus cendoscopic variceal ligation + [rp[ramp;p; pm je[atoc vein pressure gradient reduction at 1 month in patients with first episode of esophageal varix bleed: open label randomized trail. Journal of clinical and experimental hepatology, 2015; 5 (Suppl): S28.

19.Kedia S, Kurrey L, Pratap Mouli V, Dhingra R, Srivastava S, Pradhan R, Sharma R, Das P, Tiwari V, Makharia G, Ahuja V. Frequency, natural course and clinical significance of symptomatic terminal ileitis. Jounral of Digestive Diseases, 2016; 17: 36-43.

20.Khanj IA, Pillis S, Rampal R, Chauhan SK, Tiwari V, Pratap Mouli V, Kedia S, Nayak B, Das P, Makharia GK, Ahuja V. Prevalence and association of Mycobacterium avium subspecies paratuberculosis with disease course in patients with ulcero-constrictive ileocolonic disease, PLoS One, 2016; 11: e0152063.

21.Mehta R, Gahlot G, Das P, Jindal G, Pratap Mouli V, Kumble MS, Sharma R, Pal S, Ahuja V, DattaGupta S. Sclerosing mesenteric panniculitis in a young patient; common cause of diagnostic dilemma and treatment refractoriness. Acta Gastro-enterologica Belgica 2016; 79:245-6.

22.Bopanna S, Das P, Dattagupta S, Sreenivas V, Pratap Mouli V, Kedia S et at. Role of random biopsises in surveillance of dysplasia in high risk patients with ulcerative colitis. Intestinal Research, 2016; 14: 264-9.

23.Yadav DP, Madhusudhan KS, Kedia S, Sharma R,Pratap Mouli V, Dhingra R, Srivastava S, Padhan R, Kumar SN, Bopanna S, Goyal S, Jain S, Sreenivas V, Vikram NK, Makharia G, Ahuja V. Development and validation of visceral fat quantification as a surrogate marker for differentiation of Crohn’s disease and Intestinal tuberculosis. Journal of Gastroenterology and Hepatology, 2017; 32: 420-426.

24.Kedia S, Sharma R, Sreenivas V, Madhusudhan KS, Sharma V, Bopanna S, Pratap Mouli V, Dhingra R, Yadav DP, Makharia G, Ahuja V. Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn’s disease; a systematic review with meta-analysis. Intestinal Research, 2017; 15: 149-159.

25.Suraj NK, Bopanna S, Kedia S, Pratap Mouli V, Pradhan R, et al. Evaluation of Xpert MTB/RIF assay performance in diagnosis of abdominal tuberculosis and drug resistance in North India. Intestinal Research, 2017; 15: 187-194.

26.Padhan RK, Kedia S, Garg SK, Bopanna S, Pratap Mouli V, Dhingra R, Makharia G, Ahuja V. Long-term disease course and pregnancy outcomes in women with inflammatory bowel disease: an Indian cohort study. Digestive Diseases and Sciences, 2017; 62: 2054-2062.\

27.Bopanna S, Kedia S, Das P, Dattagupta S, Sreenivas V, Pratap Mouli V, et al. Long-term follow-up reveals high incidence of colorectal cancer in Indian patients with inflammatory bowel disease. United European Gastroenterology Journal, 2017; 5: 708-714.

28.Rai T, Choudhury BN, Kedia S, Bopanna S, Pratap Mouli V, et al short-term clinical response to corticosteriods can predict long term natural history of ulcertavie colitis: prospective study experience. Digestive Disease and Sciences, 2017; 62: 1025-1034.

29.Kedia S, Bhatia V, Thareja S, Garg S, Pratap Mouli V, Bopanna S, Tiwari V, Makharia G, Ahuja V. Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results form a randomized double blind placebo controlled trail. World Journal of Gastrointestinal Pharmacology and Therapeutics, 2017; 8: 147-154.

30.Dhingra R, Kedia S, Pratap Mouli V, Kumar S, Singh N, Bopanna S, et al. Evaluating Clinical, dietary and psychological risk factors for relapse of ulcertavie colitis in clinical, endosocpic and histological remission. Journal of Gastroenterology and Hepatology, 2017; 32: 1698-1705.

31.Aggarwal P, Kedia S, Sharma R, Bopanna S, Madhusudhan KS, Yadav DP, Goyal S, Jains S, Pratap Mouli V, Das P, Dattagupta S, Makharia G, Ahuja V. Tubercular intestinal strictures show a poor response to anti-tuberculous therapy, Digestive Diseases and Sciences, 2017; 62: 2847-2856.

32.Tiwari V, Kedia S, Garg SK, Rampal R, Pratap Mouli V, Purwar A, Mitra DK, Das P, Dattagupta S, Makharia G, Acharya SK, Ahuja V, CD4+ CD25+ FOXP+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease. PLoS One 2018; 28: 12:e0193433.

33.Agarwal A, Kedia S, Jain S, Gupta V, Bopanna S, Yadav DP, Goyal S, Pratap Mouli V, Dhingra R, Makharia G, Ahuja V. High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India. Intestinal Research 2018; 16: 588-598.

34.Jain S, Kedia S, Sethi T, Bopanna S, Yadav DP, Goyal S, Padhan R, Pratap Mouli V, Sahni P, Dash NR, Pal S, Makharia G, Travis SPL, Ahuja V. Predictors of long-term outcomes in patients with acute severe colitis: a northern indian cohort study. Journal of Gastroenterology and Hepatology, 2018; 33: 615-622.

35.Arora U, Ananthakrishnan AN, Kedia S, Bopanna S, Pratap Mouli V, Yadav DP, Makharia GK, Yajnik V, Ahuja V. Effect of oral tobacco use and smoking on outcomes of Crohn’s disease in India. J Gastroenterol Hepatol, 2018; 33: 134-140.

36.Kedia S, Pratap Mouli V, Kamat N, Sankar J, Ananthakrishnan A, Makharia G, Ahuja V. Risk of tuberculosis in patients with inflammatory bowel disease on infliximab or adalimumab is dependent on the local burden of tuberculosis: a systematic review and meta-analysis. Am J Gastroenterolo 2020; 115(3): 340-9.

37.Gupta A, Pratap Mouli V, Mohta S, Kante B, Kalaivani M, Madhu D, Sahu P, Kumar S, Sharma R, Sahni P, Das P, Dutta Gupta S, Makharia G, Kedia S, Ahuja V. Anti-tubercular therapy given to differentiate Crohn’s disease from intestinal tuberculosis predisposes to stricture formation. J Crohn’s Colitis. 2020 May 5;jjaa091.doi:10.1093/ecco-jcc/jjaa091. Online ahead of print.

38.Rampal R, Kedia S, Wari MN, Madhu D, Singh AK, Tiwari V, Pratap Mouli V, Mohta S, Makharia G, Ahuja V. Prospective valiation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease. Intest Res.2020 May 8.doi:105217/ir.2019.09181. Online ahead of print.

39.Vuyyuru SK, Desai D, Kedia S, Dhoble P, Sahu P, Kante B, Agarwal S, Bopanna S, Dhingra R, Pratap Mouli V, Sharma R, Gupta SD, Makharia G, Sahni P, Ahuja V. Long-term outcomes of anti-tumour necrosis factor therapy and surgery in non perianal fistulising Crohn’s disease. JGH Open. 2021 Mar 26;5(4):420-427. Doi:10.1002/jgh3.12370.eCollection 2021 Apr.

40.Bopari G, Kedia S, Kandasamy D, Sharma R, Madhusudhan KS, Dash NR, Sahu P, Pal S, Sahni P, Panwar R, Vuyyuru SK, Kante B, Yadav DP, Pratap Mouli V, Makharia G, Ahuja V. Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn’s diseae. Eur J Clin Nutr 2021 Feb 2. doi:10.1038/s41430-021-00857-x. Online ahead of print.

41.Sachdeva K, Agarwal S, Kumar P, Mathew D, Kurrey L, Vuyyuru SK, Kante B, Sahu P, Mundhra S, Virmani S, Pratap Mouli V, Dhingra R, SharmaR, Das P, MakhariaG, Kedia S, Ahuja V. Revised algorithimic approach to differentiate between nonspecific and specific etiologies of chronic terminal ileitis. Am J Gastroenterol 2023 Jul 17.
Doi:10.14309/ajg.0000000000002334. Online ahead of print.


Chapter in Books:

1.Pratap Mouli V, Ahuja V, Pal S. Lower gastrointestinal bleeding . In: Sahni P, Nundy S, eds. Gastrointestinal hemorrhage. New Delhi: Reed Elsevier Pvt. Ltd, 2012: 52-66.

2.Singh P, Pratap Mouli V, Makharia GK. Microscopic colitis. In: Ramakrishna BS, ed. Inflammatory Bowel Disease. New Delhi: Reed Elsevier Pvt. Ltd, 2013: 46-70.

3.Pratap Mouli V, Ahuja V. Azathioprine and 6-Mercaptopurine and their practical issues. In:Tandon R, Ahuja V, ed. Inflammatory Bowel Disease. New Delhi: Macmillan Medical Communications, 2013: 115-126.

4.Pratap Mouli V, Ahuja V. Issues in pregnancy and children. In: Tandon R, Ahuja V, ed. Inflammatory Bowel Disease. New Delhi: Macmillan Medical Communications, 2013: 115-126.

5.Pratap Mouli V, Ahuja V. Extraintestinal manifestations. In: Tandon R, Ahuja V, ed. Inflammatory Bowel Disease. New Delhi: Macmillan Medical Communications, 2013: 115-126.
6.Ahuja V, Pratap Mouli V, Basic considerations in gastroenterology. API textbook of Medicine, edition 11, volume 1, 2018

7.Pratap Mouli V, Ahuja V. Basic considerations in gastroenterology. API textbook of Medicine, edition 10, volume 1, 2018.

8.Pratap Mouli V, Ahuja V. Chronic bowel inflammation - beyond tuberculosis and Crohn’s disease. Progress in Gastroenterology and Hepatology 2019 (an official publications of Indian Society of Gastroenterology).

9.Pratap Mouli V, Ahuja V. Biologics in IBD. In: Chattopadhyay et al, eds. GI sugrery annual, volume 25, 2019.

10.Pratap Mouli V, Ahuja V. Microbiota based management of the gastrointestinal disorders. Microbiome, Therapeutics Application and Epigenetics: Consclusion and Future Prospective, Reference Module in Food Science, Elsevier, accepted for publication.

Presentations:

1.Oral paper presentation - “Conservative treatment for infected pancreatic necrosis: a systematic review and meta-analysis” at the Digestive Diseases Week (DDW), 2012, San Diego, USA.

2.Oral paper presentation in the Young Investigator Award category - “Higher intake of vitamin A and NSAIDs are risk factors for ulcerative colitis in deep remission” at the 53rd annual conference of the Indian Society of Gastroenterology (ISGCON), 2012, Jaipur, India.

3.Poster presentation in the presidential award category - “Efficacy of conservative treatment, without necrosectomy, for infected pancreatic necrosis: a systematic review and meta-analysis” at the 53rd annual conference of the Indian Society of Gastroenterology (ISGCON), 2012, Jaipur, India.

4.Poster presentation in APDW/WCOG 2013 at Shanghai, China - “Response to trial of antitubercular therapy in patients with ulcero-constrictive intestinal disease and an eventual diagnosis of Crohn’s disease”.

5.Oral paper presentation in the Young Investigator Award category - “Anti-tubercular therapy given to differentiate Crohn’s from intestinal tuberculosis predisposes to stricture formation” at the Asia Pacific Digestive Week, 2019. Kolkata, India.

Patient videos loading...
Doctor videos loading...
News & Events loading...
Doctors talk loading...

BOOK AN APPOINTMENT

FIND A DOCTOR

Footer Loading...